ArticleMicrobiology spectrum2026
Suboptimal ceftazidime-avibactam exposure drives sequential
Feng Yang, Weiwei Yang, Jinghao Zhang, Chengkang Tang, Li Ding, Siquan Shen, Yanhao Zhou, Hongyu Zhao, Jiaojiao Zhou, Fupin Hu
Abstract read
In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Weiwei Yang *Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Jinghao Zhang *Department of Laboratory Medicine, Huadong Hospital, Fudan University, Shanghai, China.
Chengkang TangInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Li DingInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Siquan ShenInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Yanhao ZhouInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Hongyu ZhaoDepartment of Respiratory and Critical Care Medicine, Huadong Hospital, Fudan University, Shanghai, China.
Jiaojiao ZhouDepartment of Respiratory and Critical Care Medicine, Huadong Hospital, Fudan University, Shanghai, China.
Funding
China Antimicrobial Surveillance Network 2018QD100National Natural Science Foundation of China 82172311, 82302574Shanghai Antimicrobial Surveillance Network 3030231003Shanghai Municipal Health Commission 20224Y0260Shanghai Municipal Health Commission 20244Y0152
6 · The paper itselfAbstract
KPC-producing IMPORTANCE:
Indexed as
Anti-Bacterial AgentsAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesCeftazidimeKlebsiella InfectionsKlebsiella pneumoniaeDrug CombinationsDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsMutationThird Generation CephalosporinsAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesCeftazidimeDrug CombinationsThird Generation CephalosporinsblaKPC evolutionceftazidime-avibactamintra-host coexistenceKlebsiella pneumoniaeKPC variantsreduced-dose therapy
Identifiers
PMID41718480
PMCPMC13055305
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390